HR. 6509In Committee
SAFE Drugs Act of 2025
Tightens federal oversight of compounded drugs by setting copy limits and requiring reporting and inspections for high-volume compounders
Plain-English overview
What this bill does
Tightens federal oversight of compounded drugs by setting copy limits and requiring reporting and inspections for high-volume compounders
Key points
- Require annual compounding reports
- Require outsourcing facility inspections
- Modify copy drug limits
Current status
Where it stands
Status
In Committee
Latest action
2025-12-09 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedHealth